Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats
- 1 February 1994
- journal article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 98 (1), 57-67
- https://doi.org/10.1007/bf01277594
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- THE EFFECT OF ADDING AMANTADINE TO OPTIMUM L-DOPA DOSAGE IN PARKINSON'S SYNDROMEActa Neurologica Scandinavica, 2009
- Current Status of Dopamine Agonists in Parkinson??s Disease ManagementDrugs, 1993
- Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted miceJournal of Neural Transmission, 1992
- Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of parkinson: Differential role of D-1 and D-2 receptorsNeurochemistry International, 1992
- Current Drug Therapy for Parkinson??s DiseaseDrugs & Aging, 1992
- An Interim Report of the Effect of Selegiline (L -Deprenyl) on the Progression of Disability in Early Parkinson’s DiseaseEuropean Neurology, 1992
- Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain studyEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- Effect of amantadine on chlorpromazine and reserpine-induced behavioral depression in the mouseNeuroscience & Biobehavioral Reviews, 1989
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975